Abstract
Tissue biopsies serve a valuable purpose – but they are far from perfect
Liquid biopsy may be a better option, if we can overcome its technical limitations
Ovarian cancer is one disease that can benefit from better biomarkers and better assays
Epigenetic biomarkers, such as methylation, may improve sensitivity and specificity in the diagnosis of ovarian cancer
| Original language | English |
|---|---|
| Publisher | The Pathologist |
| Publication status | Published - 02 Jan 2019 |
Fingerprint
Cite this
}
The Evolution of Epigenetic Biomarkers : Methylation and similar DNA biomarkers, combined with liquid biopsy, may offer better testing options for difficult cancers. / Buckley, Niamh E; Feeney, Laura; Beirne, James; Mullan, Paul.
The Pathologist. 2019, .Research output: Other contribution
TY - GEN
T1 - The Evolution of Epigenetic Biomarkers
T2 - Methylation and similar DNA biomarkers, combined with liquid biopsy, may offer better testing options for difficult cancers
AU - Buckley, Niamh E
AU - Feeney, Laura
AU - Beirne, James
AU - Mullan, Paul
PY - 2019/1/2
Y1 - 2019/1/2
N2 - At a GlanceTissue biopsies serve a valuable purpose – but they are far from perfectLiquid biopsy may be a better option, if we can overcome its technical limitationsOvarian cancer is one disease that can benefit from better biomarkers and better assaysEpigenetic biomarkers, such as methylation, may improve sensitivity and specificity in the diagnosis of ovarian cancer
AB - At a GlanceTissue biopsies serve a valuable purpose – but they are far from perfectLiquid biopsy may be a better option, if we can overcome its technical limitationsOvarian cancer is one disease that can benefit from better biomarkers and better assaysEpigenetic biomarkers, such as methylation, may improve sensitivity and specificity in the diagnosis of ovarian cancer
M3 - Other contribution
PB - The Pathologist
ER -